GOLGA2/GM130, cis-Golgi Matrix Protein, is a Novel Target of Anticancer Gene Therapy

Achievement of long-term survival of patients with lung cancer treated with conventional chemotherapy is still difficult for treatment of metastatic and advanced tumors. Despite recent progress in investigational therapies, survival rates are still disappointingly low and novel adjuvant and systemic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Chang, Seung-Hee, Hong, Seong-Ho, Jiang, Hu-Lin, Minai-Tehrani, Arash, Yu, Kyeong-Nam, Lee, Jae-Ho, Kim, Ji-Eun, Shin, Ji-Young, Kang, Bitna, Park, Sungjin, Han, Kiwon, Chae, Chanhee, Cho, Myung-Haing
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2012
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3498792/
https://ncbi.nlm.nih.gov/pubmed/22735382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.125
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki